RLESX
Price
$30.85
Change
-$0.10 (-0.32%)
Updated
Jul 31 closing price
Net Assets
975.36M
VSMAX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

RLESX vs VSMAX

RLESX vs VSMAX Comparison Chart in %
View a ticker or compare two or three
VS
RLESX vs. VSMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLESX is a Hold and VSMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 189B vs. RLESX (975M). VSMAX pays higher dividends than RLESX: VSMAX (1.21) vs RLESX (0.94). RLESX was incepted earlier than VSMAX: RLESX (18 years) vs VSMAX (26 years). RLESX (1.11) is less costly to investors than VSMAX (0.05). RLESX is a more actively managed with annual turnover of: 85.00 vs. VSMAX (17.00). RLESX has a lower initial minimum investment than VSMAX: RLESX (0) vs VSMAX (3000). RLESX annual gain was more profitable for investors over the last year : 25.88 vs. VSMAX (22.58). VSMAX return over 5 years is better than : 35.11 vs. RLESX (-16.18).
RLESXVSMAXRLESX / VSMAX
Total Expense Ratio1.070.052,140%
Annual Report Gross Expense Ratio1.110.052,220%
Fund Existence18 years26 years-
Gain YTD20.36714.588140%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets975M189B1%
Annual Yield % from dividends0.941.2178%
Returns for 1 year25.8822.58115%
Returns for 3 years19.6643.4245%
Returns for 5 years-16.1835.11-46%
Returns for 10 years15.60155.9610%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IWEDX15.310.15
+0.99%
Voya Large Cap Value W
IEIFX11.740.08
+0.69%
Invesco Equity and Income R6
COVAX15.190.03
+0.20%
Columbia Sm Cp Val and Inflection A
ALOIX44.370.07
+0.16%
Virtus International S/C Instl
BRSSX16.61-0.08
-0.48%
MFS Blended Research Small Cap Eq R2